The atypical chemokine receptor CCRL1 shapes functional CCL21 gradients in lymph nodes

Nature Immunology

Volumn 15, Issue 7, 2014, Pages 623-630

  Ulvmar, Maria H ^a,f,g   Werth, Kathrin ^b,f   Braun, Asolina ^b,g   Kelay, Poonam ^a   Hub, Elin ^a   Eller, Kathrin ^a,c   Chan, Li ^a   Lucas, Beth ^a   Novitzky Basso, Igor ^a   Nakamura, Kyoko ^a   Rülicke, Thomas ^d   Nibbs, Robert J B ^e   Worbs, Tim ^b   Förster, Reinhold ^b   Rot, Antal ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

^f UPPSALA UNIVERSITY   (Sweden)

^g UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCRL1; SECONDARY LYMPHOID TISSUE CHEMOKINE; UNCLASSIFIED DRUG; CHEMOKINE RECEPTOR CCR7; ENHANCED GREEN FLUORESCENT PROTEIN; LIGAND; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MELANOCYTE PROTEIN PMEL 17; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PROX 1;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; ENDOTHELIUM CELL; IN VITRO STUDY; LYMPH NODE; LYMPH VESSEL ENDOTHELIUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL TISSUE; ANTIGEN PRESENTATION; CELL LYSATE; EPITHELIUM CELL; IMMUNE RESPONSE; IMMUNOREACTIVITY; MICROENVIRONMENT; STROMA CELL; TISSUE SECTION;

ANIMALS; CELL MOVEMENT; CHEMOKINE CCL21; DENDRITIC CELLS; LYMPH NODES; MICE; MICE, INBRED C57BL; RECEPTORS, CCR;

EID: 84902662442     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2889     Document Type: Article

References (47)

1. von Andrian, U.H. & Mempel, T.R. Homing and cellular traffic in lymph nodes. Nat. Rev. Immunol. 3, 867-878 (2003).
2. Shakhar, G. et al. Stable T cell-dendritic cell interactions precede the development of both tolerance and immunity in vivo. Nat. Immunol. 6, 707-714 (2005).
3. Lindquist, R.L. et al. Visualizing dendritic cell networks in vivo. Nat. Immunol. 5, 1243-1250 (2004).
4. Förster, R. et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99, 23-33 (1999).
5. + regulatory T cells. J. Exp. Med. 204, 735-745 (2007).
6. Ohl, L. et al. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21, 279-288 (2004).
7. Vander Lugt, B. et al. CCR7 plays no appreciable role in trafficking of central memory CD4 T cells to lymph nodes. J. Immunol. 191, 3119-3127 (2013).
8. Förster, R., Davalos-Misslitz, A.C. & Rot, A. CCR7 and its ligands: balancing immunity and tolerance. Nat. Rev. Immunol. 8, 362-371 (2008).
9. Weber, M. et al. Interstitial dendritic cell guidance by haptotactic chemokine gradients. Science 339, 328-332 (2013).
10. Braun, A. et al. Afferent lymph-derived T cells and DCs use different chemokine receptor CCR7-dependent routes for entry into the lymph node and intranodal migration. Nat. Immunol. 12, 879-887 (2011).
11. Gosling, J. et al. Cutting edge: Identification of a novel chemokine receptor that binds dendritic cell- and T cell-active chemokines including ELC, SLC, and TECK. J. Immunol. 164, 2851-2856 (2000).
12. Townson, J.R. & Nibbs, R.J. Characterization of mouse CCX-CKR, a receptor for the lymphocyte-attracting chemokines TECK/mCCL25, SLC/mCCL21 and MIP-3β/mCCL19: comparison to human CCX-CKR. Eur. J. Immunol. 32, 1230-1241 (2002).
13. Bachelerie, F. et al. International Union of Pharmacology. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol. Rev. 66, 1-79 (2014).
14. Bachelerie, F. et al. New nomenclature for atypical chemokine receptors. Nat. Immunol. 15, 207-208 (2014).
15. Heinzel, K., Benz, C. & Bleul, C.C. A silent chemokine receptor regulates steady-state leukocyte homing in vivo. Proc. Natl. Acad. Sci. USA 104, 8421-8426 (2007).
16. Mäkinen, T. et al. PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev. 19, 397-410 (2005).
17. Comerford, I., Milasta, S., Morrow, V., Milligan, G. & Nibbs, R. The chemokine receptor CCX-CKR mediates effective scavenging of CCL19 in vitro. Eur. J. Immunol. 36, 1904-1916 (2006).
18. Comerford, I. et al. The atypical chemokine receptor CCX-CKR scavenges homeostatic chemokines in circulation and tissues and suppresses Th17 responses. Blood 116, 4130-4140 (2010).
19. Wendland, M. et al. Lymph node T cell homeostasis relies on steady state homing of dendritic cells. Immunity 35, 945-957 (2011).
20. Moussion, C. & Girard, J.P. Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules. Nature 479, 542-546 (2011).
21. Stein, J.V. et al. The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules. J. Exp. Med. 191, 61-76 (2000).
22. Gunn, M.D. et al. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 189, 451-460 (1999).
23. Vassileva, G. et al. The reduced expression of 6Ckine in the plt mouse results from the deletion of one of two 6Ckine genes. J. Exp. Med. 190, 1183-1188 (1999).
24. Rot, A. & von Andrian, U.H. Chemokines in innate and adaptive host defense: Basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 22, 891-928 (2004).
25. Sánchez-Madrid, F. & del Pozo, M.A. Leukocyte polarization in cell migration and immune interactions. EMBO J. 18, 501-511 (1999).
26. Okada, T. et al. Antigen-engaged B cells undergo chemotaxis toward the T zone and form motile conjugates with helper T cells. PLoS Biol. doi:10.1371/journal.pbio.0030150 (3 May 2005).
27. + T cells to sites of CD4 T cell-dendritic cell interaction. Nature 440, 890-895 (2006).
28. Middleton, J. et al. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 91, 385-395 (1997).
29. Pruenster, M. et al. The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity. Nat. Immunol. 10, 101-108 (2009).
30. Haessler, U., Pisano, M., Wu, M.M. & Swartz, M.A. Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19. Proc. Natl. Acad. Sci. USA 108, 5614-5619 (2011).
31. Schumann, K. et al. Immobilized chemokine fields and soluble chemokine gradients cooperatively shape migration patterns of dendritic cells. Immunity 32, 703-713 (2010).
32. Chai, Q. et al. Maturation of lymph node fibroblastic reticular cells from myofibroblastic precursors is critical for antiviral immunity. Immunity 38, 1013-1024 (2013).
33. Crick, F. Diffusion in embryogenesis. Nature 225, 420-422 (1970).
34. Naumann, U. et al. CXCR7 functions as a scavenger for CXCL12 and CXCL11. PLoS ONE 5, e9175 (2010).
35. Boldajipour, B. et al. Control of chemokine-guided cell migration by ligand sequestration. Cell 132, 463-473 (2008).
36. Venkiteswaran, G. et al. Generation and dynamics of an endogenous, self-generated signaling gradient across a migrating tissue. Cell 155, 674-687 (2013).
37. Donà, E. et al. Directional tissue migration through a self-generated chemokine gradient. Nature 503, 285-289 (2013).
38. Ulvmar, M.H., Hub, E. & Rot, A. Atypical chemokine receptors. Exp. Cell Res. 317, 556-568 (2011).
39. Nibbs, R.J.B. & Graham, G.J. Immune regulation by atypical chemokine receptors. Nat. Rev. Immunol. 13, 815-829 (2013).
40. Graham, G.J., Locati, M., Mantovani, A., Rot, A. & Thelen, M. The biochemistry and biology of the atypical chemokine receptors. Immunol. Lett. 145, 30-38 (2012).
41. Colditz, I.G., Schneider, M.A., Pruenster, M. & Rot, A. Chemokines at large: In-vivo mechanisms of their transport, presentation and clearance. Thromb. Haemost. 97, 688-693 (2007).
42. Lee, K.M. et al. D6 facilitates cellular migration and fluid flow to lymph nodes by suppressing lymphatic congestion. Blood 118, 6220-6229 (2011).
43. Fra, A.M. et al. Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6. J. Immunol. 170, 2279-2282 (2003).
44. Nakano, H. et al. Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses. Nat. Immunol. 10, 394-402 (2009).
45. Tanaka, Y., Mamalaki, C., Stockinger, B. & Kioussis, D. In-vitro negative selection of αβ-T-cell receptor transgenic thymocytes by conditionally immortalized thymic cortical epithelial-cell lines and dendritic cells. Eur. J. Immunol. 23, 2614-2621 (1993).
46. Friedl, P. & Brocker, E.B. Reconstructing leukocyte migration in 3D extracellular matrix by time-lapse videomicroscopy and computer-assisted tracking. Methods Mol. Biol. 239, 77-90 (2004).
47. + T cells. J. Exp. Med. 198, 569-580 (2003).